ArticleThe journal of headache and pain2022

Comparing the relative and absolute effect of erenumab: is a 50% response enough? Results from the ESTEEMen study.

Raffaele Ornello et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.